Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1996;141(9):1613-22.
doi: 10.1007/BF01718286.

Prevalence of hepatitis C virus and distribution of its genotypes in Northern Eurasia

Affiliations
Comparative Study

Prevalence of hepatitis C virus and distribution of its genotypes in Northern Eurasia

D K Lvov et al. Arch Virol. 1996.

Abstract

We tested hepatitis C virus (HCV) antibody in 4216 sera collected from healthy people living in European part of Russia (including Northern, North-Western, Central, Central-Blacksoil, Volga-Vyatka, Volga, and North-Caucasian regions), non-European part of Russia (the Urals, East-Siberia, and the Far-East regions) and Mongolia. Prevalence of HCV antibody varied significantly by regions, ranging from 0.7% in Central region of European part of Russia to 10.7% in Mongolia. Genotyping of HCV (into 1a, 1b, 2a, 2b, and 3a) was performed on 469 sera from blood donors and patients (in Russia, Moldova, Turkmenistan, and Mongolia) who were positive for both HCV antibody and RNA. Genotype 1b was the most dominant genotype irrespective of regions (68.9%), with the highest rate in Moldova (96%). HCV unclassifiable into genotypes 1a-to-3a was found in 28 (6.0%) samples: particularly 4 of 10 samples from Lipetzk were untypable. Overall, HCV genotypes in European part of Russia were more similar to those in European countries, while those in Eastern part of Russia more similar to China or Japan. Genotype distribution was not associated with the clinical expression of HCV disease: acute hepatitis, chronic hepatitis or liver cirrhosis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Microbiol. 1995 Jun;33(6):1679-81 - PubMed
    1. J Gen Virol. 1994 May;75 ( Pt 5):1063-70 - PubMed
    1. J Gen Virol. 1993 Nov;74 ( Pt 11):2391-9 - PubMed
    1. J Gen Virol. 1992 May;73 ( Pt 5):1131-41 - PubMed
    1. Intervirology. 1994;37(2):68-76 - PubMed

Publication types

Substances